Methyl 2-methyl-2-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)propanoate, 97%, 250mg

1-(1-Bromoethyl)-2-(difluoromethoxy)benzene, 95%, 1g

5-Bromo-2-fluoro-3-pyridinecarboxaldehyde, 95.0%, 500g

4-Chloro-2-hydroxybenzamide, 95.0%, 100mg

5-hydroxytetrahydro-2(1H)-pyrimidinone, 95.0%, 10g

Cytidine, 2'-deoxy-5-[3-[(trifluoroacetyl)amino]-1-propyn-1-yl]-, 97%, 1g

5-Borono-2-methoxybenzoic acid, 95.0%, 25g

2-Methyl-5-phenyl-thiazole-4-carboxylic acid, 95.0%, 1g

rel-(2R,3S,4R,5S)-3-(3-Chloro-2-fluorophenyl)-4-(4-chloro-2-fluorophenyl)-4-cyano-5-(2,2-dimethylpropyl)pyrrolidine-2-carboxylic acid tert-butyl ester, 97%, 100mg

(S)-4-PHENYL-2-(QUINOLIN-2-YL)-4,5-DIHYDROOXAZOLE, 95%, 250mg

(R)-(-)-3-Aminopiperidine Dihydrochloride>97.0%(T)200mg

2,5-Dimethylcyclohexanone (mixture of isomers)>95.0%(GC)5mL

tert-Butyl 2-(4-bromo-1H-pyrazol-1-yl)acetate, 97.0%, 25g